Relative Strength Chart Celltrion, Inc.
Equities
A068270
KR7068270008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161,200.00 KRW | +1.38% |
|
-0.37% | -10.59% |
| 06-19 | Celltrion Healthcare UK Limited Opens New UK Headquarters in Uxbridge, UK | CI |
| 06-16 | Celltrion, Inc. Announces U.S. FDA Approval of Additional Presentation of Steelara®? (Ustekinumab-Stba) | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLTRION, INC. | Other Biotechnology & Medical Research | +1.38% | -0.37% | -10.59% | -1.66% | -40.29% | 26.25B |  |  |  |
- Stock Market
- Equities
- A068270 Stock
- Charts Celltrion, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition